Insel Gruppe
Insel Gruppe is recorded as a service provider in 4 clinical trials. Explore its recorded services, study phases and therapeutic areas, with trial-level operational learnings where available.
Clinical trial experience
Showing 4 of 4 trials · Latest update first
A Phase 3 Double-masked, Randomized, Multicenter Study of the Efficacy and Safety of OCS-01 Eye Drops in Subjects With Diabetic Macular Edema
Sponsor Oculis Operations S.a.r.l.
- Start (EU)
- Not reported
- Latest update
- Estimated end
A Phase 2/3 Double-masked, Randomized, 2-stage, Multicenter Study of the Efficacy and Safety of OCS-01 Eye Drops in Subjects With Diabetic Macular Edema
Sponsor Oculis Operations S.a.r.l.
- Start (EU)
- Latest update
- Estimated end
A prospective randomized, double-blind, placebo-controlled, multi-center phase III study to evaluate the efficacy and safety of mocravimod as an adjunctive and maintenance treatment in adult acute myeloid leukemia (AML) patients undergoing allogeneic hematopoietic cell transplantation (HCT)
Sponsor Priothera S.A.S.
- Start (EU)
- Latest update
- Estimated end
Effects of ziltivekimab versus placebo on coronary atherosclerosis in patients with acute myocardial infarction. A serial, multivessel, intravascular ultrasound, near-infrared spectroscopy and optical coherence tomography imaging study
Sponsor Novo Nordisk A/S
- Start (EU)
- Latest update
- Estimated end
Questions about this trial experience
What services are recorded for Insel Gruppe?
The 2026-10-09 snapshot links Insel Gruppe to 4 distinct CTIS trials. Recorded services include Central Imaging Reader for OCT (Optical Coherence Tomography), Central Imaging Reader for OCT (Optical Coherence Tomography), Fluorescein Angiography (FA), and Color Fundus Photography (CFP)., Kit building and sample shipment, Laboratory services. These are study-specific roles, not a complete or independently verified capability catalogue.
Which therapeutic areas and study phases are recorded for Insel Gruppe?
The most frequently recorded therapeutic areas are Ophthalmology, Cardiology, Endocrinology, Haematological Malignancies. Recorded phases include Phase 3. Use the filters to inspect the supporting studies; missing tags are not evidence of absent experience.
In which countries are trials linked to Insel Gruppe conducted?
The linked trials record locations in 12 countries, including Spain, Italy, Germany, France, Austria. These are trial locations, not confirmed office locations or countries where Insel Gruppe delivered services.
What can this page tell me about Insel Gruppe's trial experience?
Browse 4 distinct trials with recorded roles, sponsor names, available study dates and links to CTIS source records. No trial-level operational findings are recorded in this snapshot. Trial counts and findings do not measure the provider’s performance or establish responsibility for study outcomes.
About this data & company names
One current approved profile per CTIS trial. Services reflect recorded roles, not a complete capability catalogue or a performance ranking. Missing tags mean the information was not recorded. Country tags describe trial locations, not the provider’s service territory.
Start is the reported EU start date; latest update is the CTIS publication date; estimated end is the reported global estimate, which may be in the past. Missing dates are shown as “Not reported”. Operational learnings describe the trial as a whole and do not establish the provider’s responsibility.
Clear service synonyms are grouped; otherwise the source label is retained. Service tags show the recorded roles for each trial. This page groups 1 recorded name variant under Insel Gruppe. Legacy brands remain separate unless explicitly matched in the name registry.
View recorded company names
- Insel Gruppe AG